PerkinElmer Solutions to Combat the Omicron SARS-CoV-2 Variant | The performance of PerkinElmer SARS-CoV-2 RT-PCR Detection Kits is not impacted by mutations associated with the Omicron variant.
Rise in Flu and RSV Infections | The Center for Disease Control and Prevention RSV National Trends Report shows that respiratory syncytial virus (RSV) is already on the rise this season.
The PerkinElmer® COVID-19 Antigen Test has been approved by the National Sanitary Surveillance Agency of Brazil (ANVISA) as a Class III in vitro diagnostic (IVD) device. This approval authorizes the sale, distribution, and use of PerkinElmer’s 15-minutes antigen test in Brazil for the qualitative detection of SARS-CoV-2, with nasal or nasopharyngeal swabs. The PerkinElmer® COVID-19 Antigen test is an accurate and efficient product to screen for the presence of COVID-19.
Watch our on-demand webinar | During the past year, laboratories across the globe have joined together to take up the fight against COVID19 by rapidly launching clinical diagnostic assays to detect affected individuals and ultimately help curb the spread of the disease.
Currently the CDC recommends that any fully vaccinated person who experiences symptoms consistent with COVID-19 be tested for SARS-CoV-2 if indicated. That leads to the question can COVID-19 vaccinations cause false positives? Here’s what we know.
Verifying the Presence of the SARS-CoV-2 in Positive RT-PCR Samples | The purpose of this study is to use Next Generation Sequencing (NGS) of samples with a range of Ct values to verify the presence of the SARS-CoV-2 genome.